PortfoliosLab logoPortfoliosLab logo
IPO Date
Nov 26, 1999

Highlights

Market Cap
$7.60B
Enterprise Value
$67.62B
EPS (TTM)
$0.16
PE Ratio
99.97
PEG Ratio
1.39
Total Revenue (TTM)
$21.54B
Gross Profit (TTM)
$5.69B
EBITDA (TTM)
$8.99B
Year Range
$15.10 - $17.82
ROA (TTM)
0.07%
ROE (TTM)
1.44%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Biophan Technologies, Inc

Performance

BIPH Performance Chart

Biophan Technologies, Inc (BIPH) is up 3.1% since the beginning of the year. At $16 per share, BIPH is trading 7.6% below its 52-week high of $18. Investors who bought $1,000 worth of BIPH shares 5 years ago would now be looking at an investment worth $911.


Loading charts...

S&P 500 Index

Returns By Period

Biophan Technologies, Inc (BIPH) has returned 3.07% so far this year and 10.62% over the past 12 months.


Biophan Technologies, Inc

1D
-1.67%
1M
-1.08%
YTD
3.07%
6M
1.22%
1Y
10.62%
3Y*
2.39%
5Y*
-1.85%
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BIPH Monthly Returns History

Based on dividend-adjusted daily data since May 26, 2021, BIPH's average daily return is 0.00%, while the average monthly return is +0.05%. At this rate, an investment would double in approximately 115.6 years.

Historically, 45% of months were positive and 55% were negative. The best month was Jan 2023 with a return of +30.9%, while the worst month was Apr 2022 at -11.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.

On a daily basis, BIPH closed higher 49% of trading days. The best single day was Mar 16, 2023 with a return of +7.8%, while the worst single day was Feb 21, 2023 at -6.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.19%-2.20%-6.37%8.87%0.61%-0.42%3.07%
202510.50%-0.60%-8.34%-2.12%-0.00%0.26%6.81%0.06%1.55%-0.06%-0.41%-1.38%5.24%
20245.18%9.63%-3.31%-7.44%2.41%2.94%-2.95%6.36%7.39%0.73%-6.09%-6.85%6.28%
202330.86%-5.16%-2.63%-5.42%3.13%5.94%-3.40%-3.80%-1.27%-8.39%6.41%5.12%17.39%
2022-5.45%-8.49%2.24%-11.27%5.30%-9.25%14.07%-9.69%-10.06%-4.38%0.44%-1.90%-34.53%
20210.16%-0.16%2.95%-0.08%1.27%-0.69%-2.90%1.52%1.98%

Benchmark Metrics

Biophan Technologies, Inc has an annualized alpha of -4.48%, beta of 0.41, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since May 27, 2021.

  • This stock participated in 124.61% of S&P 500 Index downside but only 67.80% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.41 may look defensive, but with R2 of 0.08 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-4.48%
Beta
0.41
0.08
Upside Capture
67.80%
Downside Capture
124.61%

Return for Risk

Risk / Return Rank

BIPH ranks 60 for risk / return — better than 60% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


BIPH Risk / Return Rank: 6060
Overall Rank
BIPH Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
BIPH Sortino Ratio Rank: 5555
Sortino Ratio Rank
BIPH Omega Ratio Rank: 5656
Omega Ratio Rank
BIPH Calmar Ratio Rank: 6060
Calmar Ratio Rank
BIPH Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Biophan Technologies, Inc (BIPH) and compare them to S&P 500 Index.


BIPHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.75

2.39

-1.64

Sortino ratio

Return per unit of downside risk

1.08

3.25

-2.17

Omega ratio

Gain probability vs. loss probability

1.14

1.43

-0.29

Calmar ratio

Return relative to maximum drawdown

0.96

3.11

-2.16

Martin ratio

Return relative to average drawdown

3.13

14.38

-11.26

Dividends

Dividend History

Biophan Technologies, Inc provided a 7.61% dividend yield over the last twelve months, with an annual payout of $1.25 per share.


3.00%4.00%5.00%6.00%7.00%8.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.2020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021
Dividend$1.25$1.25$1.25$1.25$1.25$0.75

Dividend yield

7.61%7.69%7.50%7.46%8.10%3.00%

Monthly Dividends

The table displays the monthly dividend distributions for Biophan Technologies, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.31$0.00$0.00$0.00$0.31
2025$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.32$1.25
2024$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$1.25
2023$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$1.25
2022$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$0.00$0.00$0.31$1.25
2021$0.44$0.00$0.00$0.32$0.75

Dividend Yield & Payout


Dividend Yield

Biophan Technologies, Inc has a dividend yield of 7.61%, which means its dividend payment is significantly above the market average.

Payout Ratio

Biophan Technologies, Inc has a payout ratio of 2,182.89%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Biophan Technologies, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biophan Technologies, Inc was 38.18%, occurring on Oct 21, 2022. The portfolio has not yet recovered.

The current Biophan Technologies, Inc drawdown is 14.44%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-38.18%Oct 2022
1y 28d
4y 8moSep 2021 - now
2021 pullback2021
-2.36%Aug 2021
4d22d
26dAug 2021 - Sep 2021
2021 pullback2021
-1.02%Jun 2021
24d11d
1mo 5dMay 2021 - Jul 2021
2021 pullback2021
-0.85%Jul 2021
4d1d
5dJul 2021 - Jul 2021
2021 pullback2021
-0.81%Jul 2021
4d3d
7dJul 2021 - Jul 2021

Drawdown Indicators


BIPHBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-38.18%

-56.78%

+18.60%

Max Drawdown (1Y)

Largest decline over 1 year

-11.16%

-9.10%

-2.06%

Max Drawdown (3Y)

Largest decline over 3 years

-22.01%

-18.90%

-3.11%

Max Drawdown (5Y)

Largest decline over 5 years

-38.18%

-25.43%

-12.75%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-14.44%

0.00%

-14.44%

Average Drawdown

Average peak-to-trough decline

-18.38%

-10.72%

-7.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.41%

1.97%

+1.44%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Biophan Technologies, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Biophan Technologies, Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for BIPH, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/E ratio of 100.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for BIPH compared to other companies in the Medical Instruments & Supplies industry. BIPH currently has a PEG ratio of 1.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BIPH relative to other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BIPH in comparison with other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with BIPH

Add Biophan Technologies, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with BIPH